Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.41B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$818M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$658M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$415M |
| 5 |
Microsoft
MSFT
|
+$400M |
Top Sells
| 1 |
The Communication Services Select Sector SPDR Fund
XLC
|
+$349M |
| 2 |
Consolidated Edison
ED
|
+$158M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$151M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$148M |
| 5 |
Chevron
CVX
|
+$131M |
Sector Composition
| 1 | Technology | 15.79% |
| 2 | Financials | 10.59% |
| 3 | Healthcare | 10.41% |
| 4 | Communication Services | 8.58% |
| 5 | Consumer Discretionary | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPB
2501
DELISTED
Opus Bank Common Stock
OPB
| $687K | ﹤0.01% |
32,503
+18,511
| +132% | +$391K |
|
2502
Veeco
VECO
$1.52B
| $685K | ﹤0.01% |
56,122
+17,955
| +47% | +$219K |
|
|
VEDL
2503
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $685K | ﹤0.01% |
67,314
+56,720
| +535% | +$577K |
|
2504
NIO
NIO
$14B
| $684K | ﹤0.01% |
268,110
+7,110
| +3% | +$18.1K |
|
2505
Enterprise Financial Services Corp
EFSC
$2.24B
| $682K | ﹤0.01% |
16,393
+8,840
| +117% | +$368K |
|
2506
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $682K | ﹤0.01% |
5,425
-1,900
| -26% | -$239K |
|
2507
Nomad Foods
NOMD
$2.12B
| $680K | ﹤0.01% |
31,848
+7,144
| +29% | +$153K |
|
2508
SFL Corp
SFL
$1.06B
| $680K | ﹤0.01% |
54,361
+29,512
| +119% | +$369K |
|
2509
LeMaitre Vascular
LMAT
$2.09B
| $677K | ﹤0.01% |
24,199
+13,494
| +126% | +$378K |
|
2510
TriCo Bancshares
TCBK
$1.48B
| $673K | ﹤0.01% |
17,807
+9,300
| +109% | +$351K |
|
|
AEGN
2511
DELISTED
Aegion Corp
AEGN
| $672K | ﹤0.01% |
36,490
+13,826
| +61% | +$255K |
|
2512
Allogene Therapeutics
ALLO
$251M
| $671K | ﹤0.01% |
25,006
-5,005
| -17% | -$134K |
|
2513
Red Robin
RRGB
$121M
| $667K | ﹤0.01% |
21,805
-25,463
| -54% | -$779K |
|
|
CEQP
2514
DELISTED
Crestwood Equity Partners LP
CEQP
| $666K | ﹤0.01% |
18,603
-13,674
| -42% | -$490K |
|
2515
American Vanguard Corp
AVD
$160M
| $665K | ﹤0.01% |
43,230
+7,319
| +20% | +$113K |
|
2516
CEVA Inc
CEVA
$564M
| $663K | ﹤0.01% |
27,238
-5,943
| -18% | -$145K |
|
|
IPHS
2517
DELISTED
Innophos Holdings, Inc.
IPHS
| $663K | ﹤0.01% |
22,769
+7,350
| +48% | +$214K |
|
2518
Berry Corp
BRY
$257M
| $658K | ﹤0.01% |
62,065
+27,744
| +81% | +$294K |
|
2519
V2X
VVX
$1.7B
| $657K | ﹤0.01% |
16,213
+7,256
| +81% | +$294K |
|
|
TVRD
2520
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $657K | ﹤0.01% |
849
-931
| -52% | -$720K |
|
|
DOVA
2521
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $653K | ﹤0.01% |
46,324
+42,657
| +1,163% | +$601K |
|
|
LTRPA
2522
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $651K | ﹤0.01% |
52,454
-65,208
| -55% | -$809K |
|
2523
Equity Bancshares
EQBK
$800M
| $647K | ﹤0.01% |
24,267
+20,410
| +529% | +$544K |
|
2524
Denali Therapeutics
DNLI
$2.07B
| $642K | ﹤0.01% |
30,912
+17,184
| +125% | +$357K |
|
|
TRTX
2525
TPG RE Finance Trust
TRTX
$742M
| $637K | ﹤0.01% |
32,986
-36,325
| -52% | -$701K |
|